RECALL ON AUVI-Q EPINEPHRINE AUTO-INJECTORS

Please be advised that Sanofi has voluntarily recalled the Auvi-Q epinephrine auto-injectors citing the possibility of the device delivering a wrong-sized dose.  You may call (866)726-6340 to get information on how to return your Auvi-Q and get a refund or cost of a new injector. 

Follow this link for more information:  www.Auvi-Q.com

In June 2015, the FDA approved a new medication called Mepolizumab for the treatment of severe eosinophilic asthma in patients 18 years or older.  This is an exciting advancement in the treatment of asthma for those patients who are on high doses of inhaled steroids and continue to have regular exacerbations, frequent visits to emergency rooms or hospitalizations or are dependent on steroids such as prednisone.  This new medication has been shown to reduce rates of hospitalizations or ER visits and also reduce rates of asthma exacerbation. Dr. Kim feels that Mepolizumab will be a potent medication to help control severe asthma.  Ask the doctors at Sunshine Allergy about your  medications if your asthma is difficult to control.
http://www.reuters.com/article/2015/06/11/us-glaxosmithkline-asthma-fda-idUSKBN0OR2N720150611

Welcome to Sunshine Allergy!

Please check back on our page for news, information, and educational material relating to Sunshine Allergy & Allergy Education.